Literature DB >> 7927489

T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

S Ying1, S R Durham, M R Jacobson, S Rak, K Masuyama, O Lowhagen, A B Kay, Q A Hamid.   

Abstract

We have investigated the phenotype of interleukin-4 (IL-4) mRNA+ cells in the nasal mucosa of six subjects with allergic rhinitis before and 24 hr after local allergen provocation with grass pollen extract. Serial cryostat sections were cut from paraformaldehyde-fixed snap-frozen nasal biopsies, and immunocytochemistry (APAAP) followed by in situ hybridization performed on the same sections. For immunocytochemistry, antibodies against CD3, tryptase, major basic protein (MBP) and CD68 were used to identify T cells, mast cells, eosinophils and macrophages, respectively. Hybridization studies were performed using a digoxigenin-labelled IL-4 riboprobe. Nitroblue tetrazolium (NBT) and X-phosphate-5-bromo-4-chloro-3-indoly phosphate (BCIP) served as chromogens to detect hybridization IL-4 mRNA signals. Significant increases in T lymphocytes and eosinophils and in the number of IL-4 mRNA+ cells were observed after allergen challenge. Double immunocytochemistry/in situ hybridization demonstrated that the majority of IL-4 mRNA+ cells after allergen challenge were CD3+ (73.7% +/- 1.6). Lower numbers of IL-4 mRNA hybridization signals were co-localized to tryptase+ cells (26.0% +/- 1.6). In contrast, no IL-4 mRNA hybridization signals were co-localized to either eosinophils or macrophages. These results indicate that after allergen challenge T cells are the principal cellular source of IL-4 mRNA transcripts during human late nasal responses, with a lesser contribution from mast cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927489      PMCID: PMC1414815     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.

Authors:  S R Durham; S Ying; V A Varney; M R Jacobson; R M Sudderick; I S Mackay; A B Kay; Q A Hamid
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils.

Authors:  V A Varney; M R Jacobson; R M Sudderick; D S Robinson; A M Irani; L B Schwartz; I S Mackay; A B Kay; S R Durham
Journal:  Am Rev Respir Dis       Date:  1992-07

3.  IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.

Authors:  R Moser; J Fehr; P L Bruijnzeel
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

4.  Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration.

Authors:  D M Briscoe; R S Cotran; J S Pober
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

5.  Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.

Authors:  A Tsicopoulos; Q Hamid; V Varney; S Ying; R Moqbel; S R Durham; A B Kay
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells.

Authors:  O Abehsira-Amar; M Gibert; M Joliy; J Thèze; D L Jankovic
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

7.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors:  R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

8.  The effect of IL-4 on human nasal mucosal responses.

Authors:  B E Emery; M V White; Y Igarashi; J Mullol; C Berkebile; D Peden; M T Lotze; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1992-11       Impact factor: 10.793

9.  Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.

Authors:  A M Bentley; Q Meng; D S Robinson; Q Hamid; A B Kay; S R Durham
Journal:  Am J Respir Cell Mol Biol       Date:  1993-01       Impact factor: 6.914

10.  Interleukin 4 is localized to and released by human mast cells.

Authors:  P Bradding; I H Feather; P H Howarth; R Mueller; J A Roberts; K Britten; J P Bews; T C Hunt; Y Okayama; C H Heusser
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  10 in total

1.  Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

Authors:  J B Travers; Q A Hamid; D A Norris; C Kuhn; R C Giorno; P M Schlievert; E R Farmer; D Y Leung
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Th1/Th2 balance in atopy.

Authors:  T Biedermann; M Röcken
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

4.  Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells.

Authors:  Irene H Heijink; Edo Vellenga; Peter Borger; Dirkje S Postma; Jan G R de Monchy; Henk F Kauffman
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

5.  Endothelial adhesion molecules for nasal-homing T cells in allergy.

Authors:  M G Karlsson; H B Hellquist
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 6.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

7.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells.

Authors:  R Pawankar; M Okuda; H Yssel; K Okumura; C Ra
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

Authors:  K Masuyama; M R Jacobson; S Rak; Q Meng; R M Sudderick; A B Kay; O Lowhagen; Q Hamid; S R Durham
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Inflammatory patterns of allergic and nonallergic rhinitis.

Authors:  S E Sobol; P Christodoulopoulos; Q A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

10.  Effects of particulate matter on allergic respiratory diseases.

Authors:  Jin-Zhun Wu; Dan-Dan Ge; Lin-Fu Zhou; Ling-Yun Hou; Ying Zhou; Qi-Yuan Li
Journal:  Chronic Dis Transl Med       Date:  2018-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.